Wisconsin Legislature: CSB 2.012 Note

(sr) Stenbolone.

(t) Testolactone.

(tg) Testosterone.

(tr) Tetrahydrogestrinone.

(u) Trenbolone.

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-018: cr. Register April 2024 No. 820, eff. 5-1-24.

CSB 2.93 Addition of Daridorexant to schedule IV. Section 961.20 (2) (cpm), Stats., is created to read:

961.20 (2) (cpm) Daridorexant;

CSB 2.94 Addition of seven (7) synthetic benzimidazole-opioid substances to schedule I. (1) Section 961.14 (2) (mm) and (pe), Stats., are renumbered to 961.14 (2) (xm) 3. and 5. and amended to read:

961.14 (2) (xm) 3. Etonitazene (2-(2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

961.14 (2) (xm) 5. Isotonitazene (N,N -diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benizimidazol-1-yl)ethan-1-amine).

(2) Section 961.14 (2) (xm) (intro.) 1., 2., 4., and 6. to 9., Stats., are created to read:

(2) (xm) Synthetic Benzimidazole-opioid Substances, specifically including all of the following:

1. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

2. Etodesnitazene also known as Etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine).

4. Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1- amine).

6. Metodesnitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

7. Metonitazene (N,N-diethyl-2-(2-(4- methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).

8. N-pyrrolidino etonitazene also known as etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)-1H-benzimidazole).

9. Protonitazene (N,N-diethyl-2-(5-nitro-2-(4- propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine).

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; correction in numbering of (1), (2) made under s. 13.92 (4) (b) 1., Stats., and correction in (1) made under s. 35.17, Stats., Register August 2022 No. 800; CR 23-020: cr. Register April 2024 No. 820, eff. 5-1-24; correction made under s. 35.17, Stats., Register April 2024 No. 820; (2) is amended to correct an error in transcription Register June 2025 No. 833.

CSB 2.95 Addition of Ganaxolone to schedule V. Section 961.22 (11), Stats., is created to read:

961.22 (11) Ganaxolone. Ganaxolone.

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2022 No. 800, eff. 7-25-22; (title) created under s. 13.92 (4) (b) 2., Stats, Register August 2022 No. 800; CR 23-021: cr. Register April 2024 No. 820, eff. 5-1-24; (title) created under s. 13.92 (4) (b) 2. Register April 2024 No. 820.

CSB 2.96 Addition of Amineptine to schedule I. Section 961.14 (7) (r), Stats., is created to read:

961.14 (7) (r) 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid, commonly known as Amineptine.

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23; correction made under s. 35.17, Stats., Register March 2023 No. 807; CR 23-068: cr. Register August 2024 No. 824, eff. 9-1-24.

CSB 2.97 Addition of Zipeprol to schedule I. Section 961.14 (2) (zm), Stats., is created to read:

961.14 (2) (zm) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol).

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23: CR 23-069: cr. Register August 2024 No. 824, eff. 9-1-24.

CSB 2.98 Excluding [18F]FP-CIT from schedule II. Section 961.16 (2) (b), Stats., is amended to read:

961.16 (2) (b) Coca leaves and any salt, compound, derivative, or preparation of coca leaves. Decocainized coca leaves or extractions which do not contain cocaine or ecgonine are excluded from this paragraph. [123I]Ioflupane is and [18 F]FP-CIT are excluded from this paragraph. The following substances and any of their salts, esters, isomers, and salts of esters and isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23; CR 24-004: cr. Register May 2025 No. 833, eff. 6-1-25.

CSB 2.99 Addition of Mesocarb to schedule I. Section 961.14 (7) (s), Stats., is created to read:

961.14 (7) (s) N-phenyl-N’-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate, commonly known as Mesocarb.

History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2023 No. 807, eff. 3-6-23; CR 24-005: cr. Register May 2025 No. 833, eff. 6-1-25.